Indicated to reduce the risk of thromboembolism from the left atrial appendage in patients with nonvalvular atrial fibrillation who are at increased risk for stroke and systemic embolism based on CHADS2 or CHA2 DS2 -VASc scores and are recommended for anticoagulation therapy, are deemed by their physicians to be suitable for warfarin, and have an appropriate rationale to seek a nonpharmacologic alternative to warfarin, taking into account the safety and effectiveness of the device compared to warfarin
Boston Scientific Corporation
Watchman Left Atrial Appendage Closure Device
Watchman Access System
21, 24, 27, 30, 33
Femoral venous access and interatrial septum crossing into the left atrium
Indicated to reduce the risk of thromboembolism from the left atrial appendage in patients with nonvalvular atrial fibrillation who are at increased risk for stroke and systemic embolism based on CHADS2 or CHA2 DS2 -VASc scores and are recommended for anticoagulation therapy, are deemed by their physicians to be suitable for warfarin, and have an appropriate rationale to seek a nonpharmacologic alternative to warfarin, taking into account the safety and effectiveness of the device compared to warfarin
Advertisement
Advertisement
We value keeping the Device Guide up to date.
If you want to add or update your company’s device listings, please let us know!